News
A new app which collates older people’s health indicators and monitors for flu symptoms supports nurses and carers to make remote diagnoses and treat patients in their homes, reducing hospitalisations.
The device will sell for $69.99 and ship in December.
The company said its valuation is now $1.4 billion.
The latest round follows a $14 million Series B raise from 2019.
The company said the Series B brings its total raise to $20 million.
The internet cognitive behavioural therapy programme will launch in 2022.
The POGO system was first cleared by the FDA in 2016.
The company plans to put the new funds towards building out its platform.
The effort will be focused on using nocturnal scratch as an endpoint for atopic dermatitis.
The firm will provide its AI-powered platform to Kantonsspital Baselland.